Dr. Omar Amirana leads the strategic direction and development of the Life Sciences portfolio and is currently the CEO of LuxCath, SciFluor and Biotectix. Omar previously served as Partner at Oxford Bioscience Partners, a Boston-based venture capital firm with ~$1B under management. There he led the Series A investment in nFocus Neuromedical (brain aneurysm therapy) which was sold to Covidien for ~$100M. Omar has served on a number of boards and is currently on the board of CardioFocus as well as the Ignition Awards Committee at BU. He has held varying operating roles in 5 startups as well as VP of Business Development at St Jude Medical (STJ). Omar is passionate about the beach, sports, and travel and enjoys spending time with his wife, baby daughter, and dog.